3.9 Article

The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception

Journal

REGULATORY PEPTIDES
Volume 111, Issue 1-3, Pages 191-197

Publisher

ELSEVIER
DOI: 10.1016/S0167-0115(02)00285-9

Keywords

sarmesin; PTZ generalized seizure model; PTZ kindling; PTZ seizure threshold; passive avoidance test; paw pressure nociceptive assay

Ask authors/readers for more resources

The present research studies the effects of sarmesin [Sar(1)Tyr(OMe)(4)] Angiotensin II (ANG II), an analogue of ANG II, on the seizure susceptibility, memory activity and nociception. It was found that this octapeptide, administered i.c.v., dose-dependently decreased the seizure intensity (pentylenetetrazol (PTZ) generalized seizure model and PTZ kindling) and augmented PTZ seizure threshold in mice. Sarmesin impaired the memory upon re-testing of rats 24 h later in the passive avoidance test. It decreased the pain threshold in a paw pressure nociceptive assay in rats. ANG II exerted pronociceptive effect as well. Taken together, these results reveal sarmesin as a behaviorally active peptide in the studied experimental animal models. (C) 2002 Elsevier Science B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available